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Introduction
Traumatic Brain Injury (TBI) research is evolving. The
quest for level-1 evidence through randomised prospective
interventional trials, while useful to establish safety and
efficacy, is changing to an era of big data observational stu-
dies. Comparative Effectiveness Research (CER) utilises the
observation of differences between treatments and centres
without strict inclusion/exclusion criteria or formal inter-
vention [1]. In addition, the transfer of monitoring technol-
ogies into the pre-hospital field will enable research into
earlier, more critical phases of brain injury. These two
changes in TBI research direction should enable a better
understanding of the spectrum of TBI diseases and foster a
future of precision, personalised TBI management.
Global epidemic of TBI
Trauma is the commonest cause of death in under 45s and
TBI the commonest cause of this death [2]. Many survi-
vors sustain considerable morbidity with lifelong effects
for them, their family and society. In the US approximately
5.3 million live with disability following TBI. In Europe,
this number is estimated to be 7.7 million [3] with 30-70%
suffering on-going mental illness [4]. Despite this, TBI fails
to attract research funding appreciated by more recognisa-
ble diseases such as cancer and heart disease.
Problems with current TBI research
TBI classification
TBI is traditionally classified as mild, moderate or severe
based on initial Glasgow Coma Score (GCS) however, clin-
ical experience tells us this is inaccurate. Patients with a
GCS of 15 can die from an extradural and GCS 3 patients
can be normal post-epileptic seizure. Approximately 25%
of “mild” head injuries do not return to work and 84%
have problems one year after injury, questioning how
“mild” these injuries really are. Such classification is not
appropriate for precision research. TBI is not one disease
but a heterogenous collection (extradural/subdural, diffuse
axonal etc) the outcome of which is determined by multi-
ple factors such as injury location, physiology, extracranial
injuries, and constitutional effects of the patient. Similarly,
treatments are heterogeneous varying between centres and
clinicians. Statistical adjustments (e.g. for extracranial inju-
ries) are often inadequate and large observational studies
are often retrospective. Whilst these may confirm com-
mon sense (e.g. treatment at a neurosciences centre
improves outcome [5]; they also run the risk of generating
self-fulfilling prophecy (e.g. the belief elderly patients do
badly alters their care [6].
Interventional trials
“Level 1” evidence studies can be contrived for ethical or
logistical purposes. Surgical intervention studies usually
require surgeon equipoise before randomisation [7,8].
Do such results apply across the entire disease spectrum
if only those in equipoise were entered? Neuroprotec-
tion drug administration within minutes of injury is dif-
ficult; hence most studies have a window of opportunity
(e.g. 8 hours). Such studies have had a negative outcome
[9,10], however, neurons die within minutes of ischae-
mia and such logistical delays may create a type II error
masking a real neuroprotective effect if given early.
Most interventional trials dichotomise outcomes but this
can be clinically irrelevant and statistically inefficient. For
example, a patient expected to be in vegetative state,
owing to intervention, moves to a severely disabled state.
Two novel approaches, sliding dichotomy and propor-
tional odd models, overcome these inefficiencies. Sliding
dichotomy requires patient stratification according to
baseline risk and a point of dichotomy is identified [11].
For patients stratified in poor prognosis group, survival
might be most relevant, whereas for those with a good
prognosis any outcome worse than good recovery is unde-
sirable. Robust prediction models are essential for such
strategies [12]. Currently 2 models are available: CRASH
and IMPACT while good at predicting death, fail toLondon’s Air Ambulance and the Pan London Neurotrauma Group, London,
UK
Wilson et al. Scandinavian Journal of Trauma, Resuscitation and Emergency
Medicine 2014, 22(Suppl 1):A7
http://www.sjtrem.com/content/22/S1/A7
© 2014 Wilson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
predict functional outcome. A large observational study of
3626 patients attempting to validate these risk prediction
models, concluded that the IMPACT model was well cali-
brated for 6 months mortality but substantially under-pre-
dicted the risk of unfavorable outcome [12]. Large purpose
built registries will refine such models.
Currently a number of fundamental neurotrauma
principals (e.g. ICP monitoring) are being questioned
[13]. An open mind is required to think again through
these basic tenants.
Timing of studies
Most acute TBI research occurs on intensive care, a con-
trolled safe environment. However, the time of greatest sec-
ondary injury is likely to be in the pre-hospital environment
with hypoxia, hypotension, and expanding haematoma
causing more neurological damage. It is this environment
where intervention will have the greatest impact.
The future of TBI research
Big data
A pragmatic approach to TBI research is required. A large
European observational study of 5400 TBI patients is about
to start (http://www.center-tbi.eu). Using CER (across
three strata of Emergency Department, Ward and Intensive
Care admissions) and by studying treatment and outcome
variations, best practice should be identified. Further colla-
boration with TrackTBI (the US TBI data portal) should
harmonise TBI common data element collection.
Pre-hospital research
Many pre-hospital interventions (intubation, thoracotomy,
blood administration) have been introduced in services
like London’s Air Ambulance. If pre-hospital neuropathol-
ogy assessment could be achieved, then roadside persona-
lised neurotrauma treatment may be possible. This has
started in stroke medicine with dispatch of CT enabled
ambulances to potential stroke patients [14]. On scene
imaging enables rapid thrombolysis. Similarly earlier neu-
roprotective interventions may be possible with on scene
TBI diagnosis.
Pan-london neurotrauma group
London is in a unique position for TBI data collection.
The capital (daytime population = 12 million) is serviced
by four major trauma centres, each receiving from one
ambulance service (London Ambulance Service) and
one Air Ambulance (London’s Air Ambulance). Addi-
tionally, all four receive severely injured patients from
South East England via county air ambulances. This
results in a population coverage of 16-18 million. The
capital contains some of the top UK academic institu-
tions that also have areas of specific interest within
brain injury research. The pan-london neurotrauma
group (http://www.londonneuro.com) will coordinate
both clinical guideline development and academic colla-
boration. By creating an on-going prospective neuro-
trauma registry future interventional studies will be
easier to instigate and run.
Conclusion
TBI is a major global problem, but new ways of studying
it, both by collecting large quantities of data and by
studying the early evolution of neurological injury offer
the most exciting opportunities yet to better understand
brain injury and provide disease targeted management
plans.
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